Product analysis
Hawthorn 1050 mg offers a simple, low-cost hawthorn supplement for people interested in heart support. Findings depend on specific extracts, so they do not establish the same benefit from this unspecified preparation.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality20
The hawthorn preparation is unspecified. That matters because heart-related findings concern particular, carefully defined extracts.
Ingredient Transparency63
The hawthorn quantity is stated, making servings easy to compare by weight. The preparation is not identified, limiting closer comparisons with specific extracts.
Value For Money100
The labeled serving compares very favorably on cost. The low cost does not establish equivalence to the specific hawthorn extracts behind clinical findings.
Customer Satisfaction87
Customer feedback is strongly positive across a large review base. The number of reviews makes the satisfaction pattern less dependent on a few opinions.
Product Focus73
The single-herb formula stays closely focused on heart-related interest. Clinical findings are conflicting and preparation-specific, so routine benefits remain uncertain.
- Format
Capsule - Container
- 180 VegCap(s)
- Per serving
- $0.20
- Also available
Hawthorn 525 mg$10.39- Customer rating
- 4.7 · 3,199 ratings
Goals
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Hawthorn | 1050 mg |
How this ingredient is rated
Composition and Label Disclosure29
Marker and Preparation Disclosure
Species Name Disclosure
Composition and Label Disclosure
Commercial Price and Usability100
Commercial Price per Labeled Serving
Alternative products
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- Real world effectiveness of Hawthorn special extract WS 1442 in a retrospective cohort study from Germany.
- Hawthorn (Crataegus spp.) Clinically Significantly Reduces Blood Pressure in Hypertension: A Meta-Analysis of Randomized Placebo-Controlled Clinical Trials.
- A randomised double blind placebo controlled clinical trial of a standardised extract of fresh Crataegus berries (Crataegisan) in the treatment of patients with congestive heart failure NYHA II.
- [Crataegus Special Extract WS 1442. Assessment of objective effectiveness in patients with heart failure (NYHA II)].
- Prospective, comparative cohort studies and their contribution to the benefit assessments of therapeutic options: heart failure treatment with and without Hawthorn special extract WS 1442.
- [Actions of standardized extracts of Crataegus berries on exercise tolerance and quality of life in patients with congestive heart failure].
- Hawthorn extract for treating chronic heart failure: meta-analysis of randomized trials.
- Clinical efficacy of crataegus extract WS 1442 in congestive heart failure NYHA class II.
- Baseline severity but not gender modulates quantified Crataegus extract effects in early heart failure--a pooled analysis of clinical trials.